Coffee Is Kind to Your Kidneys

 

Coffee Is Kind to Your Kidneys


By By Robert Preidt HealthDay Reporter, HealthDay Reporter


(HEALTHDAY)

TUESDAY, June 7, 2022 (HealthDay News) -- There's more good news for coffee lovers who already reap its other health benefits -- your favorite beverage may also help protect your kidneys.

Recommended Videos
Powered by AnyClip
Drinking Coffee May Be Linked to Lower Risk of Death
12.9K
Play Video
Drinking Coffee May Be Linked to Lower Risk of DeathNOW PLAYING
Eating This Food Can Sharply Lower Your Risk of Cardiovascular Disease
These 7 Conditions Drastically Impact Your Risk for Severe COVID-19
This Is How a COVID-19 Infection Could Damage Your Brain
NY man needs new kidney
"We already know that drinking coffee on a regular basis has been associated with the prevention of chronic and degenerative diseases including type 2 diabetes, cardiovascular disease and liver disease," said study author Dr. Chirag Parikh, director of the Division of Nephrology at Johns Hopkins University School of Medicine.

"We can now add a possible reduction in AKI [acute kidney injury] risk to the growing list of health benefits for caffeine," he said in a university news release.

Parikh and colleagues analyzed data on more than 14,000 U.S. adults who were recruited for an atherosclerosis (hardened arteries] risk study between 1987 and 1989 at a median age of 54.

The participants were surveyed seven times over 24 years about the number of 8-ounce cups of coffee they had each day: zero, one, two to three, or more than three. During the survey period, nearly 1,700 cases of acute kidney injury were recorded. AKI is a "sudden episode of kidney failure or kidney damage that happens within a few hours or a few days," according to the National Kidney Foundation.

The researchers found that people who drank any quantity of coffee every day had a 15% lower risk of acute kidney injury, and those who drank two to three cups a day had a 22% to 23% lower risk.

The study was published recently in the journal Kidney International Reports.

"We suspect that the reason for coffee's impact on AKI risk may be that either biologically active compounds combined with caffeine or just the caffeine itself improves perfusion and oxygen utilization within the kidneys," Parikh said. "Good kidney function and tolerance to AKI -- is dependent on a steady blood supply and oxygen."

Further research is needed to find out exactly how coffee may protect the kidneys. Adding milk, cream or sugar could also influence AKI risk and warrant further investigation, the researchers noted.

But reassuring research published last month found that having a little sugar with your coffee was still linked to a lower risk of dying prematurely.

More information

There's more on acute kidney injury at the National Kidney Foundation.

SOURCE: Johns Hopkins University, news release, June 2, 2022

Copyright © 2022 HealthDay. All rights reserved.

Comments

Popular posts from this blog

WEDNESDAY, June 8, 2022 (HealthDay News) -- Even after vaccination, living with HIV ups the odds for COVID infection, new research shows. Recommended Videos Powered by AnyClip Pfizer’s 3-Dose Vaccine 80% Effective Against Omicron Infection for Youngest Children 1.4K Play Video Pfizer’s 3-Dose Vaccine 80% Effective Against Omicron Infection for Youngest ChildrenNOW PLAYING This Is How a COVID-19 Infection Could Damage Your Brain Top 5 Symptoms of ‘Breakthrough’ COVID-19 White House Warns COVID-19 Cases Could Double Late This Year Are Boosted Americans More Likely To Catch COVID-19? The study found that vaccinated people living with HIV have a 28% higher risk of developing a "breakthrough" COVID infection compared to those who don't have the AIDS-causing virus. That’s the bad news. But there's good news, too: The overall risk for COVID infection among people vaccinated with at least the two primary doses remains low, regardless of their HIV status. “We thought we might see an increase in the risk of breakthrough in people with HIV because of the impact of HIV on the immune system and the role of the immune system in responding to vaccination and infection from a virus like SARS-Cov-2," reasoned study author Keri Althoff. So, the researchers weren't surprised to find "that about 4 in 100 people with HIV experience a breakthrough, compared to 3 in 100 people without HIV," said Althoff, an associate professor in the Johns Hopkins School of Public Health epidemiology department. But it was a relief, she said, to see that nine months after vaccination, "the rate and risk of breakthrough is low among vaccinated people with and without HIV" -- around 4% in each group. Her team analyzed data on nearly 114,000 COVID-vaccinated men and women, of whom 33,000 had HIV. Most were 55 years and up, 70% were white, and more than 9 in 10 were men. The authors focused on COVID risk during the latter half of 2021, when the more contagious Omicron variant emerged. Althoff noted that breakthrough infections were higher across the board -- regardless of HIV status -- in December, when Omicron became the dominant strain. Beyond identifying the 28% higher risk for a breakthrough infection among those with HIV, the researchers noted that certain individuals with HIV faced a higher infection risk than others. They included people under age 45, compared with those between 45 and 54. Risk was also higher among those who had not received a third (or booster) dose, and those with a prior infection. Risk of breakthrough infection in folks with HIV also increased as their T-cell counts dropped. According to the U.S. National Library of Medicine, T-cells are critical infection-fighting white blood cells which are typically attacked by HIV. (When an HIV patient's T-cell count falls to an extremely low level, it is often a sign of transition to full-blown AIDS.) Althoff said she and her colleagues "hypothesize that HIV-induced immune dysfunction may be playing a role in vulnerability to breakthrough COVID-19 illness." For that reason, boosters may be critical for such patients, she said. Currently, Althoff pointed out, third-dose boosters are recommended for those whose HIV is either untreated or advanced. "To increase protection against breakthrough infections, all people with HIV may need an additional dose in their primary series," she noted. That thought was echoed by Dr. Joel Blankson, a professor of medicine at Johns Hopkins Medicine, who was not part of the study. Because the study showed a decrease in breakthrough infections in patients who had received a third vaccine dose, "it is important that people living with HIV get a booster dose when they are eligible," Blankson said. The U.S. Centers for Disease Control and Prevention has COVID vaccine guidelines here. Additional research by Althoff's team suggests that hospitalization risk for breakthrough cases is higher among HIV-positive people compared to those without HIV. (Those findings are still under peer review and are not yet published.) Her advice to those with HIV: "Get vaccinated. Get boosted. Keep living your life and scale up and down your mitigation strategies -- mask-wearing, attending indoor gatherings, etc. -- based on the amount of COVID-19 transmitting in your community, and your personal health status." Dr. Thomas Gut is associate chair of medicine at the Zucker School of Medicine at Hofstra/Northwell in New York City. "The HIV-linked risk of reinfection is somewhat expected," said Gut, who had no role in the study. "In many other infectious diseases besides COVID, it's been known that patients with HIV do tend to have higher risk of both getting sick and having poorer outcomes." But patients with HIV "that have strong immune cell counts have traditionally been known to be better protected from infections compared to those with low immune system counts," he added. "It appears that COVID reinfection risk follows this same pattern." Therefore, Gut said, it is important to keep HIV infection under control as best as possible. The findings are in the June 7 issue of JAMA Network Open. More information There's more on HIV status and COVID-19 at HIV.gov. SOURCES: Keri N. Althoff, PhD, MPH, associate professor, epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore; Joel N. Blankson, MD, PhD, professor, medicine, Johns Hopkins Medicine, Baltimore; Thomas Gut, DO, associate chair, medicine, and director, ambulatory care services, Zucker School of Medicine at Hofstra/Northwell, Staten Island, N.Y.; JAMA Network Open, June 7, 2022 Copyright © 2022 HealthDay. All rights reserved.

Experts Urge Germany's Govt to Prepare for Fall COVID Wave

New Vaccine May Be Option for Troops With Religious Concerns